bio.org/Asia • #BIOASIA16 Audience Demographics The 13 th Annual BIO Asia International Conference is an exclusive, customized partnering forum that brings together U.S. and European drug development companies with Asian biotech and pharmaceutical companies interested in research collaborations and licensing agreements. Attendees will gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market. March 15-16, 2016 • Grand Hyatt, Tokyo, Japan ASIA International Conference ▲ Drug development and discovery companies ▲ Medical technology companies ▲ Universities and institutes ▲ Intellectual property and legal organizations ▲ Investors and financial services providers ▲ Bio-clusters and incubators ▲ Government and public support agencies Who Should Attend: Large Pharma: 34% Biotech: 38% Other: 18% Government/Academic/Tech Transfer: 6% Bank/Investor: 4% Attendance by Region: ® Co-hosted by U.S.: 31% Europe: 19% Asia: 17% Japan: 28% 400 DELEGATES 25 COUNTRIES 40 COMPANY PRESENTATIONS 800 ONE-ON-ONE PARTNERING MEETINGS OVER 200 COMPANIES REPRESENTED MORE THAN Highlight/Statistics from Prior Year: Company Type:
Transcript
bio.org/Asia • #BIOASIA16
Audience Demographics
The 13th Annual BIO Asia International Conference is an exclusive, customized partnering forum that brings together U.S. and European drug development companies with Asian biotech and pharmaceutical companies interested in research collaborations and licensing agreements. Attendees will gain insights into the changes, challenges, and opportunities key opinion and policy leaders foresee for the Japanese biotech market.
March 15-16, 2016 • Grand Hyatt, Tokyo, Japan
ASIAInternational Conference
▲ Drug development and discovery companies
▲ Medical technology companies
▲ Universities and institutes
▲ Intellectual property and legal organizations
▲ Investors and financial services providers
▲ Bio-clusters and incubators
▲ Government and public support agencies
Who Should Attend:
Large Pharma: 34%
Biotech: 38%
Other: 18%
Government/Academic/Tech Transfer: 6%
Bank/Investor: 4%
Attendance by Region:
®Co-hosted by
U.S.: 31% Europe: 19% Asia: 17%
Japan: 28%
400DELEGATES
25COUNTRIES 40
COMPANYPRESENTATIONS
800ONE-ON-ONE PARTNERING
MEETINGS
OVER200COMPANIES
REPRESENTED
MORE THAN
Highlight/Statistics from Prior Year:
Company Type:
bio.org/Asia • #BIOASIA16
Contact us today!
Event Attributes and Opportunities:
ASIAINTERNATIONAL CONFERENCE
▲ Expanded programming featuring government and policy experts from Japan and the U.S. who will speak on new initiatives to support international market expansion and accelerate technology transfer from university research discoveries into commercialization. Special panels on emerging deal-making trends, research collaboration tips, and Japanese drug development policy reforms.
▲ Featured speakers include Dr. Tatsuya Kondo, Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA) Japan; Dr. Makoto Suematsu, President, Japan Agency for Medical Research and Development, and Christophe Weber, Representative Director, President & CEO, Takeda.
▲ Opportunity for organizations to deliver company presentations, providing increased visibility in front of a global audience of biotech and pharmaceutical companies, all interested in cross-border business development alliances.
▲ BIO One-on-One Partnering™ enables attendees to:
• Search company and investor profiles, drug assets, products, and services in the biopharma industry;
• Evaluate potential collaborations and funding opportunities with participating companies;
• Communicate directly with prospective investors and senior business and scientific management from the U.S., Europe, and Asia; and
• Pre-schedule private, 30 minute One-on-One meetings to be conducted onsite. BIO will begin to schedule mutually accepted meetings in mid-March.
▲ Network with government leaders, peers, investors, and potential partners attending the conference and our exclusive welcome reception.
Contact us today for a tailored sponsorship package that will meet your business objectives.
